Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Reshape Lifesciences Inc (RSLS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 3,794
  • Shares Outstanding, K 11,159
  • Annual Sales, $ 1,290 K
  • Annual Income, $ -33,820 K
  • 60-Month Beta 2.71
  • Price/Sales 1.38
  • Price/Cash Flow N/A
  • Price/Book 0.01
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2,429.31
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 04/01/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3000 +16.00%
on 03/13/19
0.3890 -10.54%
on 02/26/19
-0.0270 (-7.20%)
since 02/15/19
3-Month
0.1710 +103.51%
on 12/31/18
0.5000 -30.40%
on 12/19/18
-0.0920 (-20.91%)
since 12/18/18
52-Week
0.1710 +103.51%
on 12/31/18
3,423.0000 -99.99%
on 03/19/18
-3,338.6521 (-99.99%)
since 03/16/18

Most Recent Stories

More News
Small Cap Biotech Stocks on the Rise

HENDERSON, NV / ACCESSWIRE / December 28, 2018 / Small cap securities in the biotechnology industry are always of interest to investors because several events can help increase the stock's share price...

OBLN : 1.66 (-6.74%)
NVAX : 0.52 (+1.96%)
RSLS : 0.3480 (+2.35%)
ReShape Lifesciences Acquires Lap-Band System in Exchange for ReShape Balloon

Transaction Brings Broadly Reimbursed Product with MeaningfulRevenue to ReShape

APEN : 3.32 (unch)
RSLS : 0.3480 (+2.35%)
Apollo Endosurgery, Inc. Announces the Sale of Its Surgical Product Line

Apollo Endosurgery, Inc. ("Apollo") (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced the sale of its Surgical...

APEN : 3.32 (unch)
RSLS : 0.3480 (+2.35%)
ReShape Lifesciences Expands International Business in the Middle East

SAN CLEMENTE, CA / ACCESSWIRE / December 6, 2018 / ReShape Lifesciences Inc. (NASDAQ: RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, today announced that...

RSLS : 0.3480 (+2.35%)
ReShape Lifesciences Announces Live Surgery Course for ReShape Vest

SAN CLEMENTE, CA / ACCESSWIRE / December 3, 2018 / ReShape Lifesciences Inc. (NASDAQ: RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, today announced that...

RSLS : 0.3480 (+2.35%)
ReShape Lifesciences Provides Financing and Corporate Update

Closing on Recent Financings Resulting in $25 Million in Gross Proceeds Company Funded to Support Current Operations Into 2020

RSLS : 0.3480 (+2.35%)
4 Healthcare Stocks Seeing New Highs On Monday

CORAL GABLES, FL / ACCESSWIRE / November 26, 2018 / remain popular during the latest bout of selling pressure within the broader markets. Despite potential drug-price controls, investors are seeing a...

BIOS : 2.34 (-15.83%)
NVAX : 0.52 (+1.96%)
RSLS : 0.3480 (+2.35%)
ReShape Lifesciences Announces $10 Million Registered Direct Offering

SAN CLEMENTE, CA / ACCESSWIRE / November 26, 2018 / ReShape Lifesciences Inc. (NASDAQ: RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, today announced...

RSLS : 0.3480 (+2.35%)
ReShape Lifesciences Announces Third Quarter 2018 Financial Results

ReShape Lifesciences Inc. (NASDAQ: RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, today reported financial results for the three months ended September...

RSLS : 0.3480 (+2.35%)
4 Healthcare Stocks Investors Should Get Familiar With

CORAL GABLES, FL / ACCESSWIRE / November 14, 2018 / The is the sector of the economy made up of companies that specialize in products and services related to health and medical care. According to reports...

IMMY : 5.69 (+9.63%)
TDOC : 63.10 (+0.38%)
RSLS : 0.3480 (+2.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators fully support a continuation of the trend.

See More Share

Trade RSLS with:

Key Turning Points

2nd Resistance Point 0.3627
1st Resistance Point 0.3553
Last Price 0.3480
1st Support Level 0.3353
2nd Support Level 0.3227

See More

52-Week High 3,423.0000
Fibonacci 61.8% 2,115.4792
Fibonacci 50% 1,711.5854
Fibonacci 38.2% 1,307.6917
Last Price 0.3480
52-Week Low 0.1710

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar